Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q2 2018 · 10-Q
Revenue$66.71M$66.71M+9.7% vs Q2 2017 Net Income$8.76M$8.76M+78.8% vs Q2 2017 EPS Diluted$0.43$0.43+79.2% vs Q2 2017 Gross Profit$23,479,000+30.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$4,407,000−70.0% Free Cash Flowderived$4,100,000−64.1% Margins · derivedGross margin35.2%+5.5 pt vs Q2 2017
Operating margin18.4%+5.6 pt vs Q2 2017
Net margin13.1%+5.1 pt vs Q2 2017
ended Sep 30, 2017 · filed Oct 31, 2017 · 31 d after period end